PharmaShots | Incisive News in 3 Shots

Subscribe Now

AETHERA study

Seattle Genetics Reports Multiple Results of Adcetris (Brentuximab Vedotin) in P-III ECHELON-1- P-I/II- P-II and P-III AETHERA study in Patients with Hodgkin Lymphoma at ISHL 2018

Seattle Genetics Reports Multiple Results of Adcetris (Brentuximab Vedotin) in P-III ECHELON-1- P-I/II- P-II and P-III AETHERA stu...

October 26, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us